Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Revista De Medicina De La Universidad De Navarra
|
December 30, 2004
[Past, present and future of anti-idiotype vaccination]
M Rodríguez Calvillo, S Inogés, A López Díaz de Cerio, et al.
Haematologica
|
January 1, 1994
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma
P L Zinzani, M G Levrero, F Lauria, et al.
Leukemia & Lymphoma
|
June 1, 1996
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma
P L Zinzani, M Zompatori, M Bendandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients
P L Zinzani, M Magagnoli, P Galieni, et al.
Haematologica
|
December 20, 1999
Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients
P L Zinzani, M Magagnoli, L Moretti, et al.
Blood
|
June 1, 1997
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma
P L Zinzani, E Pavone, S Storti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2010
Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma
M Bendandi, S Marillonnet, R Kandzia, et al.
Nature Medicine
|
September 30, 1999
Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma
M Bendandi, C D Gocke, C B Kobrin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma
P L Zinzani, M Magagnoli, L Moretti, et al.
Haematologica
|
December 20, 1999
How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
P L Zinzani, M Martelli, M Magagnoli, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Revista De Medicina De La Universidad De Navarra
|
December 30, 2004
[Past, present and future of anti-idiotype vaccination]
M Rodríguez Calvillo, S Inogés, A López Díaz de Cerio, et al.
Haematologica
|
January 1, 1994
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma
P L Zinzani, M G Levrero, F Lauria, et al.
Leukemia & Lymphoma
|
June 1, 1996
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma
P L Zinzani, M Zompatori, M Bendandi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients
P L Zinzani, M Magagnoli, P Galieni, et al.
Haematologica
|
December 20, 1999
Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients
P L Zinzani, M Magagnoli, L Moretti, et al.
Blood
|
June 1, 1997
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma
P L Zinzani, E Pavone, S Storti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 25, 2010
Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma
M Bendandi, S Marillonnet, R Kandzia, et al.
Nature Medicine
|
September 30, 1999
Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma
M Bendandi, C D Gocke, C B Kobrin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma
P L Zinzani, M Magagnoli, L Moretti, et al.
Haematologica
|
December 20, 1999
How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
P L Zinzani, M Martelli, M Magagnoli, et al.
Page
of 8